Genetic Analysis of Retinal Ganglion Cell Function, Development and Disease
Genetic Analysis of Retinal Ganglion Cell Function, Development and Disease
批准号:
8543735
负责人:
Thomas M. Glaser
金额:
$34.76万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2015-06-30
关键词:
AdultAffectBacterial Artificial ChromosomesBlindnessBrainCell CycleCell physiologyCellsCommitDataDependenceDevelopmentDiphtheria ToxinDiseaseDrosophila genusEmbryonic EyeExposure toEyeFeedbackGlaucomaGoalsHealthHourHumanKineticsLaboratory miceLateralLightMessenger RNAMitosisMitoticModelingMultipotent Stem CellsMusNeurogliaNeuronsOptic NervePathogenesisPathologyPathway interactionsPhotoreceptorsProcessProteolysisReporterRetinaRetinalRetinal ConeRetinal Ganglion CellsSeriesSignal TransductionStem cellsSystemTestingTimeTransgenesTransgenic MiceVascular ProliferationWild Type Mousecell fate specificationcell typecohortcompetence factorflyganglion cellgenetic analysishorizontal cellimaginal discimprovedinhibitor/antagonistmalformationmutantnotch proteinnoveloptic cupprogenitorprogramsretinal neuronretinal rodsretinogenesistranscription factortransdifferentiationvisual information
中文摘要
描述(申请人提供):视网膜神经节细胞(RGCs)是青光眼发病机制的主要靶点,也是视杯中有丝分裂祖细胞发育的第一种细胞类型。bHLH转录因子Math5在细胞周期结束后短暂表达,是RGC发生所必需的。通过Cre-lox谱系分析和BAC转基因小鼠,我们确定了5%的成年视网膜神经元来自有丝分裂后的Math5+细胞,但只有1 / 9的Math5+前体发育为RGC。这些细胞是完全多能的,无论它们的命运选择如何,它们都表达相同水平的Math5。在Math5突变体中,谱系标记的细胞形成了除RGCs外的所有主要细胞类型。因此,Math5是RGC命运规范的一个能力因素——必要但不充分。神经节细胞的发育还需要其他的积极或消极因素。Notch信号已知可抑制RGC命运,但尚不清楚Notch是否在祖细胞或有丝分裂后细胞中起作用(在Math5之前或之后),以及Notch是否影响Math5谱系中的次要命运选择。当我们激活Math5+细胞中的Notch时,它们最初发育为视网膜神经元,但转分化为Muller胶质细胞。当我们在承诺的光感受器中表达Math5时,多能性恢复。本课题研究小鼠Math5+细胞的可塑性以及形成RGCs所需的下游因子。我们的目标是:(1)通过使用BAC转基因(追踪接受Notch信号的Math5后代的命运,并以快速或缓慢的动力学驱动或阻断Math5+细胞中的Notch)和视网膜外植体,验证小鼠视网膜中初生细胞表达Math5并发展为RGC作为默认命运的假设,以及Notch是Math5+细胞中RGC命运的主要抑制剂;(2)通过在光感受器和神经节细胞前体中交叉表达Math5和Nrl,来评估它们作为RGC和杆状细胞命运的允许因子和指导因子。
英文摘要
DESCRIPTION (provided by applicant): Retinal ganglion cells (RGCs) are the primary target of glaucoma disease pathogenesis and the first cell type to develop from mitotic progenitors in the optic cup. The bHLH transcription factor Math5 is transiently expressed following cell cycle exit, and required for RGC genesis. Using Cre-lox lineage analysis and BAC transgenic mice, we have determined that 5% of adult retinal neurons derive from post-mitotic Math5+ cells, but only 1 in 9 Math5+ precursors develops into an RGC. These cells are fully multipotent and express equivalent levels of Math5 regardless of their fate choice. In Math5 mutants, the lineage-marked cells form all major cell types except RGCs. Math5 is thus a competence factor - necessary but not sufficient - for RGC fate specification. Additional positive or negative factors are needed for ganglion cell development. Notch signaling is known to inhibit RGC fate, but it is unclear whether Notch acts in progenitors or post-mitotic cells (before or after Math5), and whether Notch affects secondary fate choice in the Math5 lineage. When we activate Notch in Math5+ cells, they initially develop as retinal neurons but transdifferentiate into Muller glia. When we express Math5 in committed photoreceptors, multipotency is restored. This proposal studies the plasticity of Math5+ cells and downstream factors required to form RGCs in mice. We aim: (1) to test the hypotheses that first-born cells in the mouse retina express Math5 and develop into RGCs as a default fate, and that Notch is the major inhibitor of RGC fate in Math5+ cells, using BAC transgenes - to trace fates of Math5 descendants that receive Notch signals, and to drive or block Notch in Math5+ cells with rapid or slow kinetics, in mutant and wild-type mice - and retinal explants; and (2) to evaluate Math5 and the Nrl as permissive and instructive factors for RGC and rod fates, by cross-expressing them in photoreceptor and ganglion cell precursors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Homeotic hotspot in the human genome for eye and brain disease
-
批准号:10666455
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2022
-
负责人:Thomas M. Glaser
-
依托单位:
Homeotic hotspot in the human genome for eye and brain disease
-
批准号:10416324
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2022
-
负责人:Thomas M. Glaser
-
依托单位:
Genetic Basis of Congenital Anophthalmia
-
批准号:7809496
-
项目类别:
-
资助金额:$36.57万
-
财政年份:2009
-
负责人:Thomas M. Glaser
-
依托单位:
Genetic Basis of Congenital Anophthalmia
-
批准号:8240499
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2009
-
负责人:Thomas M. Glaser
-
依托单位:
Genetic Basis of Congenital Anophthalmia
-
批准号:8496895
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2009
-
负责人:Thomas M. Glaser
-
依托单位:
Genetic Basis of Congenital Anophthalmia
-
批准号:8053314
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2009
-
负责人:Thomas M. Glaser
-
依托单位:
Genetic Basis of Congenital Anophthalmia
-
批准号:7634829
-
项目类别:
-
资助金额:$36.94万
-
财政年份:2009
-
负责人:Thomas M. Glaser
-
依托单位:
MODELING DIAMOND-BLACKFAN ANEMIA
-
批准号:6878323
-
项目类别:
-
资助金额:$14.77万
-
财政年份:2004
-
负责人:Thomas M. Glaser
-
依托单位:
MOUSE MINUTES: A GENETIC STUDY OF RIBOSOMAL PROTEINS
-
批准号:6941361
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2004
-
负责人:Thomas M. Glaser
-
依托单位:
MODELING DIAMOND-BLACKFAN ANEMIA
-
批准号:6954695
-
项目类别:
-
资助金额:$14.77万
-
财政年份:2004
-
负责人:Thomas M. Glaser
-
依托单位:
MOUSE MINUTES: A GENETIC STUDY OF RIBOSOMAL PROTEINS
-
批准号:6823786
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2004
-
负责人:Thomas M. Glaser
-
依托单位:
MODELING DIAMOND-BLACKFAN ANEMIA
-
批准号:7104425
-
项目类别:
-
资助金额:$14.42万
-
财政年份:2004
-
负责人:Thomas M. Glaser
-
依托单位:
MOUSE MINUTES: A GENETIC STUDY OF RIBOSOMAL PROTEINS
-
批准号:7276577
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2004
-
负责人:Thomas M. Glaser
-
依托单位:
MOUSE MINUTES: A GENETIC STUDY OF RIBOSOMAL PROTEINS
-
批准号:7105069
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2004
-
负责人:Thomas M. Glaser
-
依托单位:
GENETIC ANALYSIS OF RETINAL GANGLION CELL FUNCTION
-
批准号:6802776
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2002
-
负责人:Thomas M. Glaser
-
依托单位:
GENETIC ANALYSIS OF RETINAL GANGLION CELL FUNCTION
-
批准号:6535977
-
项目类别:
-
资助金额:$32.77万
-
财政年份:2002
-
负责人:Thomas M. Glaser
-
依托单位:
Genetic Analysis of Retinal Ganglion Cell Function, Development and Disease
-
批准号:7932709
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2002
-
负责人:Thomas M. Glaser
-
依托单位:
Genetic Analysis of Retinal Ganglion Cell Function, Development and Disease
-
批准号:8288855
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2002
-
负责人:Thomas M. Glaser
-
依托单位:
Genetic Analysis of Retinal Ganglion Cell Function, Development and Disease
-
批准号:7737955
-
项目类别:
-
资助金额:$36.16万
-
财政年份:2002
-
负责人:Thomas M. Glaser
-
依托单位:
GENETIC ANALYSIS OF RETINAL GANGLION CELL FUNCTION
-
批准号:6663236
-
项目类别:
-
资助金额:$33.1万
-
财政年份:2002
-
负责人:Thomas M. Glaser
-
依托单位:
海外基金